Phase 2 Study Of Pevonedistat Plus Azacitidine Vs Azacitidine In Patients With High-Risk Myelodisplasic Syndrome (Mds), Chronic Myelomonocytic Leukemia (Cmml) Or Acute Myeloid Leukemia (Aml) <30% Blast (Nct02610777)
HAEMATOLOGICA(2020)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要